Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Innate Pharma - Filing #2811003

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	—	36 181 EUR	—	—	—	—	—	68 033 EUR	—	—	—	—	—	—	—	—
Current assets	—	—	—	148 012 EUR	—	—	—	—	—	139 831 EUR	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	92 656 EUR	—	—	—	—	—	112 374 EUR	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	39 637 EUR	—	—	—	—	—	41 338 EUR	—	—	—	—	—	—	—	—
Revenue	—	61 641 EUR	—	—	—	—	—	—	—	—	—	—	57 674 EUR	—	—	—	—	—
Profit (loss) from continuing operations	—	7 570 EUR	—	—	—	—	—	—	—	—	—	—	57 972 EUR	—	—	—	—	—
Profit (loss) from discontinued operations	—	— EUR	—	—	—	—	—	—	—	—	—	—	131,000 EUR	—	—	—	—	—
Profit (loss)	— EUR	7 570 EUR	— EUR	—	7 570 EUR	— EUR	— EUR	— EUR	— EUR	—	— EUR	— EUR	58 103 EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR
Other comprehensive income	—	670,000 EUR	—	—	—	—	—	—	—	—	—	—	362,000 EUR	—	—	—	—	—
Comprehensive income	— EUR	6 900 EUR	324,000 EUR	—	7 570 EUR	994,000 EUR	— EUR	— EUR	— EUR	—	— EUR	362,000 EUR	57 741 EUR	— EUR	— EUR	58 103 EUR	— EUR	— EUR